An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy
Author(s) -
Minjie Luo,
Liu Liu,
Inga Peter,
Jun Zhu,
Stuart A. Scott,
Geping Zhao,
Chevonne D. Eversley,
Ruth Kornreich,
Robert J. Desnick,
Lisa Edelmann
Publication year - 2013
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2013.84
Subject(s) - smn1 , haplotype , genetics , spinal muscular atrophy , allele , biology , gene duplication , carrier testing , multiplex ligation dependent probe amplification , founder effect , population , copy number variation , prenatal diagnosis , gene , medicine , exon , genome , pregnancy , fetus , environmental health
Spinal muscular atrophy is a common autosomal-recessive disorder caused by mutations of the SMN1 gene. Spinal muscular atrophy carrier screening uses dosage-sensitive methods that determine SMN1 copy number, and the frequency of carriers varies by ethnicity, with detection rates ranging from 71 to 94% due to the inability to identify silent (2 + 0) carriers with two copies of SMN1 on one chromosome 5 and deletion on the other. We hypothesized that identification of deletion and/or duplication founder alleles might provide an approach to identify silent carriers in various ethnic groups.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom